BDX vs BOW · P/E 34, rev $21.84B vs P/E 16, rev $425.7M
Becton Dickinson and Company (BDX) versus Bowhead Specialty Holdings Inc. (BOW) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported BOW revenue for 2024-12-31 was $425.7M. Net income was $38.2M. Revenue was up 50.2% from 2023-12-31 to 2024-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Not investment advice. Open the BDX and BOW stock pages for the full models.
Not investment advice.